• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Reproducible process: Accommodating effect clearly demonstrated for two IOLs

Article

Mainz, Germany-The accommodation capabilities of two IOLs (AT-45, CrystaLens, C&C Vision, Aliso Viejo, CA; and 1CU, HumanOptics AG, Erlangen, Germany) were clearly demonstrated in patients for the first time and compared with a standard IOL, which showed no accommodative effect, according to H. Burkhard Dick, MD.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.